Queensland Bauxite (ASX: QBL)
Another week goes by, and yet another big announcement from Queensland Bauxite, who is reveling in its decision to move into the world of cannabis.
The company announcing this week that its 55%-owned subsidiary Medical Cannabis has secured an agreement to bring Canada-based Canntab Therapeutics’ pharmaceutical grade medical cannabis pills to the Australian and Asian markets.
The Canntab pills provide a constant drug concentration between 12 and 18 hours and may prove to be a threat to traditional synthetic medication produced by Big Pharma
QBL Price at posting:
6.9¢ Sentiment: Buy Disclosure: Held